References
1. Kim HJ. Therapeutic Options for Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Korean Continence Soc 2007;11:1–8.
2. Mo XW, Wang B, Li HS, Dang J, Hang L. The Scheme and Method of TCM in Treating CP. World Chinese Medicine 2013;8(10):1244–7.
3. Wang Q, Zhang JX. Clinical Research Progress of Guizhifulingwan in the Treatment of Andrology. Journal of New Chinese Medicine 2010;42(10):105–6.
4. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999;162(2):369–75.
5. Choi JY, Lee MJ, Cho SH, Kim SB, Lee ST, Min SK. Comparison of Clinical Symptoms Scored According to NIH-CPSI in Patients with Chronic Prostatitis Syndrome Category IIIa and IIIb. Korean J UTII 2011;6(1):42–7.
6. Kim HJ, Hong JH. Efficacy of Propiverine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Korean Continence Soc 2008;12(2):158–62.
7. National Administration of Traditional Chinese Medicine. Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Symptoms in Chinese Medicine Nanjing University Press; 1994. p. 698.
8. Kim JT, Kim HD, Park JS, Lee JH, Kim SY, Choi JY, et al. Study on Guideline for the Treatment of Chronic Prostatitis in Korean Medicine - Search Chinese Traditional Medical Papers from 2003~2013. Korean J Oriental Physiology & Pathology 2014;28(3):271–9.
9. Li HS, Han FL, Li WI. Study on Relationship of common traditional Chinese medicine syndromes in 918 cases of Chronic Prostatitis (CP). Beijing Journal of Traditional Chinese Medicine 2008;27(6):416–8.
10. Han LA, Wang B, Li HS. Treatment of chronic prostatitis according to the blood stasis theoretics of traditional Chinese medicine. Global Traditional Chinese Medicine 2012;5(7):488–91.
11. Zheng XD, Yan HF. Research Progress of Meridian and Collateral Disease in Recent 20 Years and Application Research Progress in Cardiac Disease. Yunnan Journal of Traditional Chinese Medicine and Materia Medica 2015;36(12):89–93.
12. Ge HN. Collateral Disease Theory of Yetianshi and its application on Miscellaneous Diseases due to internal injury. J Nanjing University TCM 2016;32(5):409–12.
13. LI H, SUN ZX. Clinical Research of Guizhifulingwan Decoction and Acupuncture in Treatment on Patients With Prostatitis III. Liaoning Journal of Traditional Chinese Medicine 2011;38(8):1557–60.
14. Yu JS. New Clinical Application of Guizhi Fuling Pill. Clinical Journal of Traditional Chinese Medicine 2006;18(6):606.
16. Lee PR, Ahn GS, Choi SH. Study on the Effects of Guizhifulingwan and Its Components on Dextran-Induced Blood Stasis and HA-Induced Elevated Blood Viscosity Models. The Kyung Hee University Oriental Medical Journal 1997;19(2):39–67.
17. Jo HG, Park AR, Kee YB, Kang DH, Choi JB, Sul JU. A Clinical Trial on the Blood Stasis and Efficacy of Kyejibokryong-whan (Guizhifuling-wan) in the Patients with Motor Vehicle Accident. J Oriental Rehab Med 2011;21(3):45–55.
18. Choi GY, Cho JH, Jang JB, Lee KS. Clinical Study on the Efficacy of Gyejibokryeong-hwan in the Treatment of Menorrhalgia. J Korean Obstet Gynecol 2004;17(1):178–86.
19. Ma Y. New clinical experience of Guizhifuling-wan. CJITWN 2010;11(8):726–7.
20. Wagenlehner FM, Oliver van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, et al. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 2013;May. 63(5):953–9.
21. Cho IR. Text Book of Andrology Seoul: Koonja; 2004. p. 571.